Identification of regulatory T cells in systemic lupus erythematosus

Autoimmunity Reviews

Volumn 8, Issue 5, 2009, Pages 426-430

  Gerli, Roberto ^a   Nocentini, Giuseppe ^b   Alunno, Alessia ^a   Bocci, Elena Bartoloni ^a   Bianchini, Rodolfo ^b   Bistoni, Onelia ^a   Riccardi, Carlo ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Department of Clinical and Experimental Medicine   (Italy)

Author keywords

CD25; Foxp3; GITR; Regulatory T cells; Systemic lupus erythematosus

Indexed keywords

GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ANTIGEN EXPRESSION; DISEASE ACTIVITY; DISEASE MARKER; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIGENS, CD4; ANTIGENS, DIFFERENTIATION; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-17; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS;

EID: 61349083564     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.01.004     Document Type: Review

References (39)

1. Askenasy N., Kaminitz A., and Yarkoni S. Mechanisms of T regulatory cell function. Autoimmun Rev 7 (2008) 370-375
2. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α chain (CD25), breakdown of a single mechanism of self tolerance causes various autoimmune disease. J Immunol 155 (1995) 1151-1164
3. Dieckmann D., Plottner H., Berchtold S., Berger T., and Schuler G. Ex vivo isolation of CD4+CD25+ T cells with regulatory properties from human blood. J Exp Med 193 (2001) 1303-1310
4. Frey O., Petrow P.K., Gajda M., Siegmund K., Huehn J., Scheffold A., et al. The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Res Ther 7 (2005) R291-R301
5. Walker M.R., Kasprowicz D.J., Gersuk V.H., Benard A., Van Landeghen M., Buckner J.H., et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest 112 (2003) 1437-1443
6. Fiocco U., Sfriso P., Oliviero F., Pagnin E., Scagliori E., Campana C., et al. Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept. Autoimmun Rev 8 (2008) 76-82
7. Chang X., Zheng P., and Liu Y. FoxP3: a genetic link between immunodeficiency and autoimmune diseases. Autoimmun Rev 5 (2006) 399-402
8. Banham A.H. Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells. Trends Immunol 27 (2006) 541-544
9. Crispin J.C., Martínez A., and Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 21 (2003) 273-276
10. Liu M.F., Wang C.R., Fung L.L., and Wu C.R. Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 59 (2004) 198-202
11. Miyara M., Amoura Z., Parizot C., Badoual C., Dorgham K., Trad S., et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 175 (2005) 392-400
12. Lee J.H., Wang L.C., Lin Y.T., Yang Y.H., Lin D.T., and Chiang B.L. Inverse correlation between CD4+ regulatory T cell population and autoantibody levels in paedriatic patients with systemic lupus erythematosus. Immunology 117 (2006) 280-286
13. Alvarado-Sanchez B., Hernández-Castro B., Portales-Pérez D., Baranda L., Layseca-Espinosa E., Abud-Mendoza C., et al. Regulatory T cells in patients with systemic lupus erithematosus. J Autoimmun 27 (2006) 110-118
14. Mellor-Pita S., Citores M.J., Castejon R., Tutor-Ureta P., Yebra-Bango M., Andreu J.L., et al. Decrease of regulatory T cells in patients with systemic lupus erythematosus. Ann Rheum Dis 65 (2006) 553-554
15. Suarez A., López P., Gómez J., and Gutiérrez C. Enrichment of CD4+CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids. Ann Rheum Dis 65 (2006) 1512-1517
16. Valencia X., Yarboro C., Illei G., and Lipsky P.E. Deficient CD4+CD25high regulatory T cell function in patients with active systemic lupus erythematosus. J Immunol 178 (2007) 2579-2588
17. Barath S., Aleksza M., Tarr T., Sipka S., Szegedi G., and Kiss E. Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus. Lupus 16 (2007) 489-496
18. Bonelli M., von Dalwigk K., Savitskaya A., Smolen J.S., and Scheinecker C. FoxP3 expression in CD4+ T cells of patients with systemic lupus erythematosus (SLE): a comparative phenotypic analysis. Ann Rheum Dis 67 (2008) 664-671
19. Lin S.C., Chen K.H., Lin C.H., Kuo C.C., Ling Q.D., and Chan C.H. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Investig 37 (2007) 987-996
20. REG) in Systemic Lupus Erythematosus (SLE) patients: the possible influence of treatment with corticosteroids. Clin Immunol 127 (2008) 151-157
21. Yates J., Whittington A., Mitchell P., Lechler R.I., Lightstone L., and Lombardi G. Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis. Clin Exp Immunol 153 (2008) 44-55
22. Zhang B., Zhang X., Tang F.L., Zhu L.P., Liu Y., and Lipsky P.E. Clinical significance of increased CD4+CD25-FoxP3+ T cells in patients with new-onset systemic lupus erythematosus. Ann Rheum Dis 67 (2008) 1037-1040
23. Bonelli M., Savitskaya A., von Dalwigk K., Steiner C.W., Aletaha D., Smolen J.S., et al. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int Immunol 20 (2008) 861-868
24. Yan B., Ye S., Chen G., Kuang M., Shen N., and Chen S. Dysfunctional CD4+CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-α-producing antigen-presenting cells. Arthritis Rheum 58 (2008) 801-812
25. Vargas-Rojas M.I., Crispín J.C., Richaud-Patin Y., and Alcocer-Varela J. Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance. Lupus 17 (2008) 289-294
26. Chowdary Venigalla R.K., Tretter T., Krienke S., Max R., Eckstein V., Blank N., et al. Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+CD25high CD127low regulatory T cells in patients with systemic lupus erythematosus. Arthritis Rheum 58 (2008) 2120-2130
27. Lee H.Y., Hong Y.K., Yun H.J., Kim Y.M., Kim J.R., and Yoo W.H. Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus. Rheumatology 47 (2008) 789-794
28. Suen J.L., Li H.T., Jong Y.J., Chiang B.L., and Yen J.H. Altered homeostasis of CD4+ FoxP3+ regulatory T-cell subpopulations in systemic lupus erythematosus. Immunology (2008) [Electronic publication]
29. Zhang B., Zhang X., Tang F., Zhu L., and Liu Y. Reduction of forkhead box P3 levels in CD4+CD25 high T cells in patients with new onset systemic lupus erythematosus. Clin Exp Immunol 153 (2008) 182-187
30. Cepika A.M., Marinic I., Morovic-Vergles J., Soldo-Juresa D., and Gagro A. Effect of steroids on the frequency of regulatory T cells and expression of FOXP3 in a patient with systemic lupus erythematosus: a two year follow-up. Lupus 16 (2007) 374-377
31. Nocentini G., Giunchi L., Ronchetti S., Krausz L.T., Bartoli A., Moraca R., et al. A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc Natl Acad Sci U S A 94 (1997) 6216-6221
32. Kwon B., Yu K.Y., Ni J., Yu G.L., Jang I.K., Kim Y.J., et al. Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand. J Biol Chem 274 (1999) 6056-6061
33. Krausz L.T., Bianchini R., Ronchetti S., Fettuciari K., Nocentini G., and Riccardi C. GITR-GITRL system, a novel player in shock and inflammation. Sci World J 7 (2007) 533-566
34. Nocentini G., Ronchetti S., Cuzzocrea S., and Riccardi C. GITR/GITRL: more than an effector T cell co-stimulatory system. Eur J Immunol 37 (2007) 1165-1169
35. Ronchetti S., Zollo O., Bruscoli S., Agostini M., Bianchini R., Nocentini G., et al. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur J Immunol 34 (2004) 613-622
36. Ramirez-Montagut T., Chow A., Hirschhorn-Cymerman D., Terwey T.H., Kochman A.A., Lu S., et al. Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity. J Immunol 176 (2006) 6434-6442
37. high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis. Cell Immunol 253 (2008) 92-101
38. + Treg cells reveals an age-dependent loss of suppressive activity. J Neurosci Res 74 (2003) 296-308
39. Lau K.M., Cheng S.H., Lo K.W., Lee S.A., Woo J.K., van Hasselt C.A., et al. Increase in circulating Foxp3+CD4+CD25(high) regulatory T cells in nasopharyngeal carcinoma patients. Br J Cancer 96 (2007) 617-622